Clinical Trial Site

Indianapolis, Indiana 46260

4 studies enrolling now · 9 studies all time

What they study most

ANCA-Associated Vasculitis, Advanced Solid Cancer, Amyloidosis, Early-Onset Alzheimer Disease, Hereditary Hemorrhagic Telangiectasia, Iron Deficiency Anemia, KRAS G12D Mutation, Leukocyte Chemotactic Factor 2 Amyloidosis, Lichen Planopilaris, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Transthyretin Amyloidosis With Cardiomyopathy

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD — Recruiting now
• A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris — Recruiting now
• A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) — Running, not enrolling
• A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation — Running, not enrolling
• A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Enrolling by invitation
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia — Completed
• A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease — Stopped early